Capt. Did U read the JPM transcript ? AMRN needs to make $ in the US market in order to fund expansion in the EU …. Otherwise they eat into cash on hand
The combo idea is mainly a carrot to retain reimbursement rates when those come up for renegotiation.
UK. Sales reps are by law limited to 2 visits a year with an MD so sales efforts are mainly digital
CB—do you or anyone else here have a fix on actual ex-US sales to date? I hear a lot about “expanding” other markets, but it’s the actual sales that are going to matter. Has the company made any projection on expected sales ex-US in 2023?